New pricing order takes effect in Spain
This article was originally published in Scrip
A pricing order increasing the number of medicines subject to reference pricing in Spain seems to have helped slow state spending on pharmaceuticals.
You may also be interested in...
Softening provisions to make EU-wide joint clinical assessments voluntary would make proposed legislation on HTA cooperation redundant, says Eurordis.
Plans for EU-wide Joint Clinical assessments will come under scrutiny at an EU council meeting next week.
Pfizer’s Ibrance has won conditional reimbursement in England while more data is gathered to reduce some uncertainty.